CTEV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CTEV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Claritev's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $57.632. Claritev's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is $0.00.
As of today (2025-03-31), Claritev's share price is $20.77. Claritev's Median PS Value is $0.00. Therefore, Claritev's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Claritev's Median PS Value or its related term are showing as below:
The historical data trend for Claritev's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Claritev Annual Data | ||||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||
Median PS Value | Get a 7-Day Free Trial | - | - | - | - | - |
Claritev Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Median PS Value | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | - | - | - | - |
For the Health Information Services subindustry, Claritev's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Claritev's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Claritev's Price-to-Median-PS-Value falls into.
Claritev's Median PS Value for today is calculated as
Median PS Value | = | Revenue per Share (TTM) | * | 10-Year Median PS Ratio |
= | 57.632 | * | 0 | |
= | 0.00 |
10-Year Median PS Ratio is 0.
Claritev's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $57.632.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Claritev (NYSE:CTEV) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Claritev's Price to Median PS Value for today is calculated as
Price to Median PS Value | = | Share Price | / | Median PS Value |
= | 20.77 | / | 0.00 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Claritev's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Michael Kim | officer: See Remarks | POLARIS PARENT CORP, 115 FIFTH AVENUE, NEW YORK NY 10003 |
Anthony Jr Colaluca | director | MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003 |
John Michael Prince | director | 115 FIFTH AVE., NEW YORK NY 10003 |
Nutter Carol | officer: SVP, Chief People Officer | 115 FIFTH AVE., NEW YORK NY 10003 |
Mark Tabak | director, officer: Chief Executive Officer | 115 FIFTH AVENUE, NEW YORK NY 10003 |
Michael K. Attal | director | 425 PARK AVENUE, 30TH FLOOR, NEW YORK NY 10022 |
James M Head | officer: EVP & Chief Financial Officer | 3001 COLORADO BLVD, DENTON TX 76210 |
Julie D Klapstein | director | 1239 FRUIT COVE ROAD NORTH, JACKSONVILLE FL 32259 |
C Martin Harris | director | |
H&f Corporate Investors Viii, Ltd. | 10 percent owner | 415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105 |
Music Investments Gp, Llc | 10 percent owner | C/O HELLMAN & FRIEDMAN, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111 |
Music Investments, L.p. | 10 percent owner | C/O HELLMAN & FRIEDMAN, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111 |
Glenn R August | director | C/O OHA - 1114 AVENUE OF THE AMERICAS, 27TH FLOOR, NEW YORK NY 10036 |
Paul Galant | officer: President, New Markets | 88 WEST PLUMERIA DRIVE, SAN JOSE CA 95134 |
Michael Stuart Klein | director, 10 percent owner, officer: Chief Executive Officer | C/O DAVIS POLK & WARDWELL, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
From GuruFocus
By GuruFocus News • 11-06-2024
By GuruFocus News • 02-14-2025
By GuruFocus News • 01-01-2025
By GuruFocus News • 01-31-2025
By GuruFocus News • 02-26-2025
By GuruFocus News • 12-30-2024
By GuruFocus News • 12-31-2024
By Business Wire • 10-22-2024
By Business Wire • 02-21-2025
By GuruFocus News • 02-25-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.